Thorac Cardiovasc Surg 2016; 64(02): 150-158
DOI: 10.1055/s-0035-1563538
Original Thoracic
Georg Thieme Verlag KG Stuttgart · New York

Survival Following Lung Metastasectomy in Soft Tissue Sarcomas

Katherine Giuliano
1   School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States
,
Teviah Sachs
2   Department of Surgery, Boston University, Boston, Massachusetts, United States
,
Elizabeth Montgomery
3   Department of Pathology, Johns Hopkins University, Baltimore, Maryland, United States
,
Angela Guzzetta
4   Department of Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, United States
,
Malcolm Brock
5   Department of Surgery, Johns Hopkins University, Baltimore, Maryland, United States
,
Timothy M. Pawlik
5   Department of Surgery, Johns Hopkins University, Baltimore, Maryland, United States
,
Stephen C. Yang
5   Department of Surgery, Johns Hopkins University, Baltimore, Maryland, United States
,
Nita Ahuja
5   Department of Surgery, Johns Hopkins University, Baltimore, Maryland, United States
› Author Affiliations
Further Information

Publication History

27 April 2015

25 June 2015

Publication Date:
04 September 2015 (online)

Abstract

Background The most common site of metastasis for soft tissue sarcomas (STSs) is the lung. In patients who are candidates for resection, metastasectomy improves survival. Debate remains, however, on approach and patient selection for surgery.

Methods We retrospectively analyzed demographics, tumor characteristics, peri- and postoperative factors for 53 patients who underwent lung metastasectomy for STS from 1989 to 2013. Disease-free intervals (DFIs) and survival were determined. Kaplan–Meier estimates and log-rank test were used for comparison and survival analyses.

Results Median overall survival (diagnosis to death or last visit) was 59.9 months (IQR: 118.5), with mean follow-up of 85.3 months (SD: 69.5). Post-lung metastasectomy survival was 82.9%, 52.2%, 28.3%, and 13.3% at 1, 3, 5, and 10 years, respectively. Age at diagnosis of less than 50 years (p = 0.037), a low pathologic grade (p = 0.040), and a DFI until metastasis of greater than 13.5 months (p = 0.007) were significant predictors of improved survival.

Conclusion Patients diagnosed at a younger age with low-grade tumors and those with a longer DFI prior to metastasis diagnosis gain the greatest survival advantage with surgery.

 
  • References

  • 1 Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63 (1) 11-30
  • 2 Potter DA, Glenn J, Kinsella T , et al. Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol 1985; 3 (3) 353-366
  • 3 Pfannschmidt J, Hoffmann H, Schneider T, Dienemann H. Pulmonary metastasectomy for soft tissue sarcomas: is it justified?. In: Tunn P, ed. Treatment of Bone and Soft Tissue Sarcomas. Vol 179. New York, NY: Springer Berlin Heidelberg; 2009: 321-326
  • 4 Robinson MH, Sheppard M, Moskovic E, Fischer C. Lung metastasectomy in patients with soft tissue sarcoma. Br J Radiol 1994; 67 (794) 129-135
  • 5 Billingsley KG, Burt ME, Jara E , et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg 1999; 229 (5) 602-610 , discussion 610–612
  • 6 Gadd MA, Casper ES, Woodruff JM, McCormack PM, Brennan MF. Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg 1993; 218 (6) 705-712
  • 7 Pfannschmidt J, Klode J, Muley T, Dienemann H, Hoffmann H. Pulmonary metastasectomy in patients with soft tissue sarcomas: experiences in 50 patients. Thorac Cardiovasc Surg 2006; 54 (7) 489-492
  • 8 Canter RJ, Qin LX, Downey RJ, Brennan MF, Singer S, Maki RG. Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity: a retrospective analysis. Cancer 2007; 110 (9) 2050-2060
  • 9 Predina JD, Puc MM, Bergey MR , et al. Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol 2011; 6 (5) 913-919
  • 10 García Franco CE, Algarra SM, Ezcurra AT , et al. Long-term results after resection for soft tissue sarcoma pulmonary metastases. Interact Cardiovasc Thorac Surg 2009; 9 (2) 223-226
  • 11 Blackmon SH, Shah N, Roth JA , et al. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 2009; 88 (3) 877-884 , discussion 884–885
  • 12 Smith R, Pak Y, Kraybill W, Kane III JM. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol 2009; 35 (4) 356-361
  • 13 Welter S, Grabellus F, Bauer S , et al. Growth patterns of lung metastases from sarcoma: prognostic and surgical implications from histology. Interact Cardiovasc Thorac Surg 2012; 15 (4) 612-617
  • 14 Stephens EH, Blackmon SH, Correa AM , et al. Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. J Am Coll Surg 2011; 212 (5) 821-826
  • 15 Sardenberg RA, Figueiredo LP, Haddad FJ, Gross JL, Younes RN. Pulmonary metastasectomy from soft tissue sarcomas. Clinics (Sao Paulo) 2010; 65 (9) 871-876
  • 16 Liebl LS, Elson F, Quaas A, Gawad KA, Izbicki JR. Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma. Anticancer Res 2007; 27 (4C): 2897-2902
  • 17 Casson AG, Putnam JB, Natarajan G , et al. Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer 1992; 69 (3) 662-668
  • 18 van Geel AN, Pastorino U, Jauch KW , et al. Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer 1996; 77 (4) 675-682
  • 19 Verazin GT, Warneke JA, Driscoll DL, Karakousis C, Petrelli NJ, Takita H. Resection of lung metastases from soft-tissue sarcomas. A multivariate analysis. Arch Surg 1992; 127 (12) 1407-1411
  • 20 Rehders A, Hosch SB, Scheunemann P, Stoecklein NH, Knoefel WT, Peiper M. Benefit of surgical treatment of lung metastasis in soft tissue sarcoma. Arch Surg 2007; 142 (1) 70-75 , 76
  • 21 Choong PFM, Pritchard DJ, Rock MG, Sim FH, Frassica FJ. Survival after pulmonary metastasectomy in soft tissue sarcoma. Prognostic factors in 214 patients. Acta Orthop Scand 1995; 66 (6) 561-568
  • 22 Chen F, Fujinaga T, Sato K , et al. Significance of tumor recurrence before pulmonary metastasis in pulmonary metastasectomy for soft tissue sarcoma. Eur J Surg Oncol 2009; 35 (6) 660-665
  • 23 Gossot D, Radu C, Girard P , et al. Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach?. Ann Thorac Surg 2009; 87 (1) 238-243
  • 24 Lin JC, Wiechmann RJ, Szwerc MF , et al. Diagnostic and therapeutic video-assisted thoracic surgery resection of pulmonary metastases. Surgery 1999; 126 (4) 636-641 , discussion 641–642
  • 25 Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 1997; 350 (9092) 1647-1654
  • 26 Weiser MR, Downey RJ, Leung DHY, Brennan MF. Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma. J Am Coll Surg 2000; 191 (2) 184-190 , discussion 190–191